PE firm Advent International acquires 51% stake in ZCL Chemicals

ZCL is one of the fastest-growing manufacturers of specialty active pharmaceutical ingredients (APIs) and advanced intermediates

Private equity firm Advent International has signed a definitive agreement to acquire a majority stake in ZCL Chemicals (ZCL), one the fastest-growing pharmaceutical firms in India. The business was formerly known as Zandu Chemicals.

According to people in the know, Advent picked up a 51 per cent stake in the entity, which has an enterprise value of Rs 1,700 crore. With this, Morgan Stanley Private Equity Asia (MSPEA), a private equity platform that previously managed a minority investment in ZCL, will exit the company.

ZCL was advised by Jefferies (Sole Financial Advisor), Bombay Law Chambers (Legal Counsel), and Deloitte (Finance and Tax).

ZCL